晚期前列腺癌对氨鲁米特和醋酸可的松的反应
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
作者信息
Ponder B A, Shearer R J, Pocock R D, Miller J, Easton D, Chilvers C E, Dowsett M, Jeffcoate S L
出版信息
Br J Cancer. 1984 Dec;50(6):757-63. doi: 10.1038/bjc.1984.253.
Abstract
Forty patients with metastatic adenocarcinoma of the prostate were evaluated for response to treatment with aminoglutethimide plus cortisone acetate. All had relapsed from or failed to respond to primary endocrine treatment with orchidectomy or stilboestrol. Nineteen patients (48%) showed subjective response, in most cases relief of bone pain. Side effects limited treatment in only 3 patients. We conclude that aminoglutethimide plus cortisone acetate is a useful addition to the treatment available for this difficult group of patients. The mechanism by which this treatment has a beneficial effect remains unclear.
摘要
对40例前列腺转移性腺癌患者进行了评估，以确定其对氨鲁米特加醋酸可的松治疗的反应。所有患者均已从睾丸切除术或己烯雌酚的初始内分泌治疗中复发或治疗无效。19例患者（48%）出现主观反应，多数情况下骨痛缓解。仅3例患者因副作用限制了治疗。我们得出结论，氨鲁米特加醋酸可的松是治疗这类难治性患者现有方法的有益补充。这种治疗产生有益效果的机制尚不清楚。
相似文献
1
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.晚期前列腺癌对氨鲁米特和醋酸可的松的反应
Br J Cancer. 1984 Dec;50(6):757-63. doi: 10.1038/bjc.1984.253.
2
Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.
J Urol. 1983 Jan;129(1):51-5. doi: 10.1016/s0022-5347(17)51916-3.
3
The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.氨鲁米特和氢化可的松单独及联合使用对睾丸切除术后前列腺癌患者雄激素水平的影响。
Br J Cancer. 1988 Feb;57(2):190-2. doi: 10.1038/bjc.1988.40.
4
Aminoglutethimide therapy for advanced carcinoma of the prostate.
Br J Urol. 1982 Oct;54(5):552-5. doi: 10.1111/j.1464-410x.1982.tb13589.x.
5
Adrenal androgen blockade in relapsed prostate cancer.
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1127-31. doi: 10.1016/0277-5379(85)90003-3.
6
[Aminoglutethimide in the treatment of advanced prostatic cancer].氨鲁米特治疗晚期前列腺癌
Urologe A. 1985 Jan;24(1):46-8.
7
Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
Cancer Res. 1987 Sep 1;47(17):4736-9.
8
Aminoglutethimide in advanced prostatic carcinoma.
Br J Urol. 1987 Apr;59(4):323-7. doi: 10.1111/j.1464-410x.1987.tb04641.x.
9
Mitomycin C and aminoglutethimide in the treatment of metastatic prostatic cancer: a phase II study.丝裂霉素C与氨鲁米特治疗转移性前列腺癌：一项II期研究。
Br J Urol. 1992 Nov;70(5):542-5.
10
Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma.
Cancer. 1984 Apr 1;53(7):1447-50. doi: 10.1002/1097-0142(19840401)53:7<1447::aid-cncr2820530703>3.0.co;2-g.
引用本文的文献
1
Roles for the backdoor pathway of androgen metabolism in prostate cancer response to castration and drug treatment.雄激素代谢的旁路途径在前列腺癌对去势和药物治疗反应中的作用。
Int J Biol Sci. 2014 Jun 3;10(6):596-601. doi: 10.7150/ijbs.8780. eCollection 2014.
2
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.福美司坦。对其药效学、药代动力学特性以及在乳腺癌和前列腺癌治疗中的潜在应用的综述。
Drugs. 1993 Jan;45(1):66-84. doi: 10.2165/00003495-199345010-00007.
3
The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.氨鲁米特和氢化可的松单独及联合使用对睾丸切除术后前列腺癌患者雄激素水平的影响。
Br J Cancer. 1988 Feb;57(2):190-2. doi: 10.1038/bjc.1988.40.
4
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.氨鲁米特作为乳腺癌内分泌治疗的作用机制
Drugs. 1988 Jun;35(6):685-710. doi: 10.2165/00003495-198835060-00005.
5
Aromatase inhibition in advanced prostatic cancer: preliminary communication.晚期前列腺癌中的芳香化酶抑制：初步交流。
Br J Cancer. 1990 Aug;62(2):275-6. doi: 10.1038/bjc.1990.276.
6
Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.芳香化酶抑制作用：4-羟基雄烯二酮（4-OHA，CGP 32349）在晚期前列腺癌中的应用。
Br J Cancer. 1992 Jul;66(1):139-42. doi: 10.1038/bjc.1992.231.
7
Aromatase inhibitors in malignant diseases of aging.芳香化酶抑制剂在衰老相关恶性疾病中的应用
Drugs Aging. 1992 Nov-Dec;2(6):530-45. doi: 10.2165/00002512-199202060-00008.
本文引用的文献
1
Cortisone treatment in advanced carcinoma of the prostate.
J Urol. 1954 Sep;72(3):485-96. doi: 10.1016/S0022-5347(17)67614-6.
2
Chemotherapy of hormone-resistant stage D prostatic cancer.
J Urol. 1980 Jun;123(6):797-805. doi: 10.1016/s0022-5347(17)56140-6.
3
Aminoglutethimide therapy for advanced carcinoma of the prostate.
Br J Urol. 1982 Oct;54(5):552-5. doi: 10.1111/j.1464-410x.1982.tb13589.x.
4
Chemohormonal therapy of metastatic prostate cancer. A pilot study.转移性前列腺癌的化学激素疗法。一项试点研究。
Cancer. 1983 Aug 1;52(3):410-4. doi: 10.1002/1097-0142(19830801)52:3<410::aid-cncr2820520305>3.0.co;2-r.
5
Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma.
Cancer. 1984 Apr 1;53(7):1447-50. doi: 10.1002/1097-0142(19840401)53:7<1447::aid-cncr2820530703>3.0.co;2-g.
6
Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.氨鲁米特对晚期乳腺癌患者血浆6-酮-前列腺素F1α和13,14-二氢-15-酮-前列腺素F2α的抑制作用
Br J Cancer. 1983 Oct;48(4):595-8. doi: 10.1038/bjc.1983.233.
7
Medical adrenalectomy with aminoglutethimide in the management of advanced breast cancer.氨鲁米特用于晚期乳腺癌治疗的医学肾上腺切除术
Med J Aust. 1981 Feb 21;1(4):179-81. doi: 10.5694/j.1326-5377.1981.tb135442.x.
8
Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
Cancer. 1980 Apr 15;45(7 Suppl):1937-46.
9
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy.接受氨鲁米特治疗的晚期乳腺癌患者复发相关的内分泌变化。
J Clin Endocrinol Metab. 1984 Jan;58(1):99-104. doi: 10.1210/jcem-58-1-99.
10
Aminoglutethimide dose and hormone suppression in advanced breast cancer.氨鲁米特剂量与晚期乳腺癌的激素抑制
Eur J Cancer Clin Oncol. 1983 Apr;19(4):493-8. doi: 10.1016/0277-5379(83)90112-8.
Zotero 插件